Chiasma Plans IPO Of 5.4 Mln Shares To Raise Up To $80.4 Million

Biopharmaceutical company Chiasma updated its filing for an initial public offering, saying it is looking to sell 5.36 million shares between $13 to $15 a share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.